-
Biotin-tyramide: TSA Mechanism & Workflow
2026-09-10
Biotin-tyramide is a biotinylation reagent for enzyme-mediated tyramide signal amplification in immunohistochemistry and in situ hybridization. Its HRP-dependent local deposition supports fluorescent or chromogenic streptavidin detection, while product-specific solvent and storage limits define reliable handling.
-
Targeted SPP1 Inhibition in Tumor-Associated Myeloid Cells
2026-09-10
The reference study establishes a phenotypic screening strategy for identifying small molecules that reduce SPP1 expression in tumor-associated macrophages and packages selected hits in a TAM-avid CANDI nanoconstruct. Its lead compound, CANDI460, lowered SPP1 in cellular and mouse studies and was associated with tumor remission across multiple murine models, supporting SPP1-high myeloid cells as a therapeutically actionable compartment.
-
BHA Workflows for Oxidative Stress Research
2026-09-09
Build reproducible BHA experiments for reactive oxygen species (ROS) detection, biomolecule protection, and redox-sensitive phenotype testing. This guide combines practical formulation controls with a stereochemistry-inspired assay framework drawn from peptide research.
-
S63845 MCL1 Inhibitor: Apoptosis Workflows
2026-09-09
S63845 provides a selective way to test MCL1 dependence, BAX/BAK-driven mitochondrial apoptosis, and cytochrome c release in cancer models. This practical guide connects dose design and troubleshooting with the emerging role of LACTB-mediated inner-mitochondrial-membrane remodeling.
-
5-Azacytidine Workflows for Leukemia Research
2026-09-08
Build stronger epigenetic experiments with 5-Azacytidine by pairing DNA methylation measurements with viability, apoptosis, and differentiation endpoints. This practical workflow also shows how to use 5-AzaC as a DNMT-focused comparator when evaluating emerging leukemia compounds with additional tubulin activity.
-
RIPA Lysis Buffer for Stroke Protein Workflows
2026-09-08
Build reproducible ischemic-brain protein workflows with strong detergent lysis and a customizable inhibitor strategy. This guide translates fecal microbiota transplantation findings into practical Western blot, immunoprecipitation, ELISA, and kinase-assay preparation decisions.
-
Dutasteride Workflow for Prostate Research
2026-09-07
Build cleaner androgen-mechanism experiments with Dutasteride, a dual 5-alpha-reductase inhibitor that connects direct DHT suppression to proliferation and apoptosis readouts. This practical guide covers stock preparation, dose-response design, assay selection, cross-study interpretation, and troubleshooting for prostate cancer and BPH models.
-
BMX-IN-1 Workflows for Kinase Research
2026-09-05
BMX-IN-1 is an irreversible BMX kinase inhibitor for connecting covalent target inhibition with cancer-cell phenotypes and host-pathogen biology. This practical guide covers dose-response design, lysosomal-acidification assays, apoptosis and cell-cycle readouts, plus troubleshooting for macrophage and tumor-cell workflows.
-
Rotigotine in Experimental Depression Models
2026-09-05
The reference study was among the first systematic evaluations of Rotigotine across several established rodent models of anxiety and depression-like behavior. Its dose- and model-dependent findings suggest antidepressant-like activity at lower exposures, while also showing why locomotor stimulation must be separated from genuine changes in affective behavior.
-
Deracoxib: COX-2 Mechanism and Research Uses
2026-09-04
Deracoxib is a selective COX-2 inhibitor used in canine pain, inflammation, and tumor-cell research. Product-reported concentration ranges support assay planning, but in vitro potency, plasma exposure, and clinical dosing should not be treated as interchangeable measures.
-
CHI3L1-IN-5: A Mechanistic Assay Guide
2026-09-04
CHI3L1-IN-5 (Compound Z17) offers a CNS-oriented way to interrogate CHI3L1-driven neuroinflammation and astrocyte dysfunction. This guide focuses on chemical identity, assay architecture, evidence boundaries, and how to interpret NF-κB and amyloid-clearance readouts without overstating translational conclusions.
-
ALOX5-Driven Ferroptosis Escape in Bladder Cancer
2026-09-03
The reference study identifies ALOX5 deficiency as a determinant of ferroptosis resistance in bladder cancer and links this defect to EGR1-dependent transcriptional regulation. Its combination of stage-stratified cell models, transcriptomics, genetic perturbation, animal validation, and clinical analysis supports ALOX5 as a potential biomarker and therapeutic target, while also defining important limits for translating ferroptosis findings into other regulated cell-death systems.
-
Trolox Beyond the Benchmark: Redox Translation
2026-09-03
Trolox is more than a routine antioxidant standard: it can serve as a mechanistic probe for separating broad redox protection from lipid peroxidation-driven cell death. This thought-leadership guide connects Trolox assay design with ferroptosis biology, oxidative injury research, neurodegeneration studies, and cancer biology research while defining the limits of translational interpretation.
-
Anlotinib in Intra-abdominal DSRCT
2026-09-02
This case report describes radiographic reduction of metastatic intra-abdominal desmoplastic small round cell tumor after anlotinib treatment, extending a multi-target tyrosine kinase inhibitor strategy into a rare, highly aggressive sarcoma. Its main value is hypothesis generation: it links an anti-angiogenic treatment rationale with a documented clinical response while also illustrating the limits of single-patient evidence.
-
Z-IETD-FMK in Caspase-8 Assays
2026-09-02
Z-IETD-FMK enables targeted dissection of caspase-8 in activated T cells, NF-κB signaling, and TRAIL-dependent cell death. This workflow also shows how to use caspase inhibition as a careful mechanistic probe when studying chicken GSDME-associated pyroptosis during RNA virus infection.